J. Strony

Sunil V. Rao, C. Held, P. Armstrong, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial

C. Held, P. Armstrong, F. Van de Werf, 2017, European heart journal. Acute cardiovascular care.

Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes

K. Mahaffey, R. Becker, M. Valgimigli, 2014, Thrombosis and Haemostasis.

Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).

P. Armstrong, F. Van de Werf, H. White, 2014, The American journal of cardiology.

Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial

C. Held, P. Armstrong, F. Van de Werf, 2012, European heart journal. Acute cardiovascular care.

Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial.

C. Held, P. Armstrong, F. Van de Werf, 2013, European heart journal.

Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).

C. Held, P. Armstrong, F. Van de Werf, 2014, Journal of the American College of Cardiology.

Prior β-blocker treatment decreases leukocyte responsiveness to injury.

S. Houser, Daohai Yu, R. Marfella, 2019, JCI insight.

Perfusion thallium imaging of type I diabetes patients with end stage renal disease: comparison of oral and intravenous dipyridamole administration.

R. Wilson, Y. Wang, J. Schwartz, 1990, Radiology.

Striated muscle safety of ezetimibe/simvastatin (Vytorin).

T. Musliner, M. Davidson, D. Maccubbin, 2006, The American journal of cardiology.

Efficacy and Safety of Vorapaxar in Non–ST‐Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

C. Held, P. Armstrong, F. Van de Werf, 2015, Journal of the American Heart Association.

Percutaneous transluminal coronary angioplasty for unstable angina: Predictors of outcome in a multicenter study

J. Bittl, B. Lewis, E. Grassman, 1994, Journal of Thrombosis and Thrombolysis.

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.

Giuseppe Ambrosio, Claes Held, Marco Valgimigli, 2012, The New England journal of medicine.

Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial

C. Held, P. Armstrong, F. Van de Werf, 2018, Journal of the American Heart Association.

The Use of Tumor Prostheses for Primary or Revision Reverse Total Shoulder Arthroplasty With Proximal Humeral Bone Loss

D. Knapik, R. Gillespie, S. Mengers, 2022, Journal of shoulder and elbow arthroplasty.

Aurintricarboxylic acid in a canine model of coronary artery thrombosis.

J. Moake, M. Phillips, B. Adelman, 1990, Circulation.

Proximal tibial replacement in revision knee arthroplasty for non-oncologic indications

Eric B. Smith, M. Cross, Gregory K. Deirmengian, 2020, Arthroplasty today.

Early versus delayed, provisional eptifibatide in acute coronary syndromes.

R. Califf, B. Lewis, R. Giugliano, 2009, The New England journal of medicine.

Musculoskeletal Infection in Orthopaedic Oncology: Assessment of the 2018 International Consensus Meeting on Musculoskeletal Infection.

P. Choong, R. O'Donnell, M. Ghert, 2019, The Journal of bone and joint surgery. American volume.

1006-43 Hirulog™ vs. Heparin During Percutaneous Transluminal Coronary Angioplasty in Patients with Post-Infarction Angina: Results of the Myocardial Infarction Arm of the Hirulog Angioplasty Trial

J. Bittl, B. Adelman, J. Strony, 1995 .

Aurintricarboxylic acid prevents acute rethrombosis in a canine model of arterial thrombosis.

B. Adelman, J. Strony, A. Song, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Worse Outcomes Are Associated with Proximal Femoral Replacement Following Periprosthetic Joint Infection.

J. Parvizi, T. Tan, D. Nazarian, 2021, The Journal of arthroplasty.

Oral Ketorolac as an Adjuvant Agent for Postoperative Pain Control After Arthroscopic Anterior Cruciate Ligament Reconstruction: A Prospective, Randomized Controlled Study

M. Salata, J. Voos, Lakshmanan Sivasundaram, 2022, The Journal of the American Academy of Orthopaedic Surgeons.

Use of A Direct Antithrombin, Hirulog, in Place of Heparin During Coronary Angioplast

E. Topol, P. Ganz, V. Kakkar, 1993, Circulation.

Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis.

A. Beaudoin, J Strony, A Beaudoin, 1993, The American journal of physiology.

Distal Femoral Replacement and Periprosthetic Joint Infection After Non-Oncological Reconstruction: A Retrospective Analysis.

J. Parvizi, G. Klein, D. Nazarian, 2021, The Journal of arthroplasty.

Protocol for a multicenter, randomised controlled trial of surgeon-directed home therapy vs. outpatient rehabilitation by physical therapists for reverse total shoulder arthroplasty: the SHORT trial

C. Cook, E. Reinke, Brian Forsythe, 2021, Archives of Physiotherapy.

Endoscopic Treatment of Calcific Tendinitis of the Gluteus Maximus: A Case Report.

M. Salata, M. Philippon, Charles A. Su, 2021, JBJS case connector.

Evaluating the role of graft integrity on outcomes: clinical and imaging results following superior capsular reconstruction.

M. Salata, Sean A Cupp, R. Gillespie, 2020, Journal of shoulder and elbow surgery.

Survivorship, complications, and outcomes following distal femoral arthroplasty for non-neoplastic indications

Brianna R. Fram, J. Strony, K. Sobol, 2022, Bone & joint open.

Cutaneous Basal Cell Carcinoma with Bone Metastases: An Orthopaedic Case Report

G. Jagannathan, Brianna R. Fram, J. Strony, 2019, Case reports in orthopedics.

Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy

C. Held, P. Armstrong, F. Van de Werf, 2016, Circulation. Cardiovascular interventions.

Effect of transient abrupt vessel closure during otherwise successful angioplasty for unstable angina on clinical outcome at six months. Hirulog Angioplasty Study Investigators.

B. Chaitman, P. Ganz, J. Bittl, 1999, Journal of the American College of Cardiology.

Risk analysis of coronary bypass surgery after acute myocardial infarction.

A. Geha, E. Lesnefsky, R. Nair, 1997, Surgery.

Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial

E. Ohman, D. Ardissino, H. Bueno, 2017, The Lancet.

Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial.

Marc P. Bonaca, E. Braunwald, D. Morrow, 2009, American heart journal.

Effects of Opioid-Limiting Legislation on Postoperative Opioid Use in Shoulder Arthroplasty in an Epidemic Epicenter.

J. Voos, R. Gillespie, Y. Raji, 2021, Journal of shoulder and elbow surgery.

The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale.

C. Held, B. Lewis, R. Diaz, 2009, American heart journal.

Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography.

Y. Wang, C. Manske, J. Sprafka, 1990, The American journal of medicine.

Evaluating the Utility of Perioperative Laboratory Tests in Primary Shoulder Arthroplasty

R. Gillespie, Y. Raji, N. Trivedi, 2023, Seminars in Arthroplasty: JSES.

Changing reimbursement models and private equity ownership in spine surgery.

H. Makanji, Matthew S. Galetta, Mark F. Kurd, 2019, Annals of translational medicine.

Quantification of the Passive Mechanical Properties of the Resting Platelet

Jason H. Haga, Armand J. Beaudoin, J. Haga, 1998, Annals of Biomedical Engineering.

Validation of the Artificial Floor Technique in First Metatarsophalangeal Joint Arthrodesis

R. Marcus, A. Rascoe, J. Strony, 2022, Clinical orthopaedics and related research.

Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial.

C. Held, P. Armstrong, F. Van de Werf, 2014, American heart journal.

Patients Who Have Undergone Total Shoulder Arthroplasty Prefer Greater Surgeon Involvement in Shared Decision-Making.

R. Gillespie, Lakshmanan Sivasundaram, Y. Raji, 2022, Journal of shoulder and elbow surgery.

The Role of Imaging in Femoroacetabular Impingement: History, Current Practices, and Future Applications.

S. Nho, M. Salata, Charles A. Su, 2021, JBJS reviews.

SCH 602539, a Protease-Activated Receptor-1 Antagonist, Inhibits Thrombosis Alone and in Combination With Cangrelor in a Folts Model of Arterial Thrombosis in Cynomolgus Monkeys

M. Chintala, S. Kurowski, Qiu Li, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Oral Ketorolac as an Adjuvant Agent for Postoperative Pain Control After Arthroscopic Rotator Cuff Repair: A Prospective, Randomized, Controlled Study

M. Salata, J. Voos, R. Gillespie, 2021, The Journal of the American Academy of Orthopaedic Surgeons.

Relation Between Coronary Calcium and 10-Year Risk Scores in Primary Prevention Patients

G. Levine, R. Harrington, P. Dohmen, 2003 .

Early Clinical and Radiographic Outcomes of Anatomic Total Shoulder Arthroplasty with a Bi-convex Posterior Augmented Glenoid for Patients with Posterior Glenoid Erosion: Minimum 2-Year Follow-Up.

G. Walch, Natasha R. Jones, E. Spencer, 2022, Journal of shoulder and elbow surgery.

Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar

C. Held, P. Armstrong, F. Van de Werf, 2016, Catheterization and cardiovascular interventions.

Early versus delayed, provisional eptifibatide in acute coronary syndromes.

R. Califf, B. Lewis, R. Giugliano, 2009, The New England journal of medicine.

Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.

C. Held, K. Alexander, P. Armstrong, 2016, American heart journal.

Prior β-blocker treatment decreases leukocyte responsiveness to injury.

S. Houser, Daohai Yu, R. Marfella, 2019, JCI insight.

The Fate of Periprosthetic Joint Infection Following Megaprosthesis Reconstruction

J. Parvizi, T. Tan, D. Nazarian, 2021, JB & JS open access.

Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design.

P. Kowey, P. Steg, Sneha S. Jain, 2024, American heart journal.

Challenges and Priorities for Research A Report From the National Heart, Lung, and Blood Institute (NHLBI)/ National Institutes of Health (NIH) Working Group on Thrombosis in Pediatric Cardiology and Congenital Heart Disease

K. Mahaffey, R. Ichord, J. Kaltman, 2014 .